DATA GRAPHICS | Product Development
Data Bytes: coronavirus-targeted small molecules
October 13, 2020 10:40 PM UTC
The SARS-CoV-2 protease is the top target for small molecule COVID-19 candidates developed with a coronavirus infection as their original indication, of which only a handful have entered the clinic.
Out of the 281 small molecule candidates in BioCentury’s COVID-19 portal, 22 were developed with SARS-CoV-2, SARS-CoV or another coronavirus as the intended target. ...